Health Trials

Rectal Cancer Recurrent

2

Review clinical trials related to Rectal Cancer Recurrent. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy

Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.

Participants needed: 65
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of AarhusUpdated: Jan 5, 2021Locations: 1
Eligibility criteria

• Locally recurrent rectal cancer. [+8]

Non-resectable distant metastases (PET-CT) [+2]

Read more
Status: Recruiting

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

JCOG1801 is a randomized phase III trial which was initiated in Japan in August 2019 to confirm the superiority of preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for local relapse-free survival over standard treatment, i.e. surgery plus adjuvant chemotherapy, for previously non-irradiated locally recurrent rectal cancer.

Participants needed: 110
Trial details
Phase: Phase 3Age: 20-80Biological sex: AllType: InterventionalSponsor: National Cancer Center Hospital EastUpdated: Jun 4, 2020Locations: 45
Eligibility criteria

Histopathologically proven adenocarcinoma or adenosquamous carcinoma on the rese... [+16]

Synchronous or metachronous (within 5 years) malignancies except cancer with 5-y... [+12]

Read more